Literature DB >> 23516287

Phosphodiesterase inhibition rescues chronic cognitive deficits induced by traumatic brain injury.

David J Titus1, Atsushi Sakurai, Yuan Kang, Concepcion Furones, Stanislava Jergova, Rosmery Santos, Thomas J Sick, Coleen M Atkins.   

Abstract

Traumatic brain injury (TBI) modulates several cell signaling pathways in the hippocampus critical for memory formation. Previous studies have found that the cAMP-protein kinase A signaling pathway is downregulated after TBI and that treatment with a phosphodiesterase (PDE) 4 inhibitor rolipram rescues the decrease in cAMP. In the present study, we examined the effect of rolipram on TBI-induced cognitive impairments. At 2 weeks after moderate fluid-percussion brain injury or sham surgery, adult male Sprague Dawley rats received vehicle or rolipram (0.03 mg/kg) 30 min before water maze acquisition or cue and contextual fear conditioning. TBI animals treated with rolipram showed a significant improvement in water maze acquisition and retention of both cue and contextual fear conditioning compared with vehicle-treated TBI animals. Cue and contextual fear conditioning significantly increased phosphorylated CREB levels in the hippocampus of sham animals, but not in TBI animals. This deficit in CREB activation during learning was rescued in TBI animals treated with rolipram. Hippocampal long-term potentiation was reduced in TBI animals, and this was also rescued with rolipram treatment. These results indicate that the PDE4 inhibitor rolipram rescues cognitive impairments after TBI, and this may be mediated through increased CREB activation during learning.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23516287      PMCID: PMC3655415          DOI: 10.1523/JNEUROSCI.5133-12.2013

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  86 in total

1.  Prevalence of long-term disability from traumatic brain injury in the civilian population of the United States, 2005.

Authors:  Eduard Zaloshnja; Ted Miller; Jean A Langlois; Anbesaw W Selassie
Journal:  J Head Trauma Rehabil       Date:  2008 Nov-Dec       Impact factor: 2.710

2.  A novel protein complex in membrane rafts linking the NR2B glutamate receptor and autophagy is disrupted following traumatic brain injury.

Authors:  Gregory E Bigford; Ofelia F Alonso; Dalton Dietrich; Robert W Keane
Journal:  J Neurotrauma       Date:  2009-05       Impact factor: 5.269

3.  Phosphorylation of calcium calmodulin-dependent protein kinase II following lateral fluid percussion brain injury in rats.

Authors:  Michael M Folkerts; Elizabeth A Parks; John R Dedman; Marcia A Kaetzel; Bruce G Lyeth; Robert F Berman
Journal:  J Neurotrauma       Date:  2007-04       Impact factor: 5.269

4.  An analysis of regional microvascular loss and recovery following two grades of fluid percussion trauma: a role for hypoxia-inducible factors in traumatic brain injury.

Authors:  Eugene Park; Joshua D Bell; Ishita P Siddiq; Andrew J Baker
Journal:  J Cereb Blood Flow Metab       Date:  2008-12-17       Impact factor: 6.200

5.  Phosphodiesterase inhibitors enhance object memory independent of cerebral blood flow and glucose utilization in rats.

Authors:  Kris Rutten; Eva L Van Donkelaar; Linda Ferrington; Arjan Blokland; Eva Bollen; Harry Wm Steinbusch; Paul At Kelly; Jos Hhj Prickaerts
Journal:  Neuropsychopharmacology       Date:  2009-03-04       Impact factor: 7.853

6.  Hypothermia treatment potentiates ERK1/2 activation after traumatic brain injury.

Authors:  Coleen M Atkins; Anthony A Oliva; Ofelia F Alonso; Shaoyi Chen; Helen M Bramlett; Bing-Ren Hu; W Dalton Dietrich
Journal:  Eur J Neurosci       Date:  2007-07-30       Impact factor: 3.386

7.  Low doses of cyclic AMP-phosphodiesterase inhibitors rapidly evoke opioid receptor-mediated thermal hyperalgesia in naïve mice which is converted to prominent analgesia by cotreatment with ultra-low-dose naltrexone.

Authors:  Stanley M Crain; Ke-Fei Shen
Journal:  Brain Res       Date:  2008-07-12       Impact factor: 3.252

8.  Deficits in ERK and CREB activation in the hippocampus after traumatic brain injury.

Authors:  Coleen M Atkins; M Cristina Falo; Ofelia F Alonso; Helen M Bramlett; W Dalton Dietrich
Journal:  Neurosci Lett       Date:  2009-05-03       Impact factor: 3.046

9.  The activity-regulated cytoskeletal-associated protein (Arc/Arg3.1) is required for memory consolidation of pavlovian fear conditioning in the lateral amygdala.

Authors:  Jonathan E Ploski; Vicki J Pierre; Jason Smucny; Kevin Park; Melissa S Monsey; Kathie A Overeem; Glenn E Schafe
Journal:  J Neurosci       Date:  2008-11-19       Impact factor: 6.167

10.  Persistent working memory dysfunction following traumatic brain injury: evidence for a time-dependent mechanism.

Authors:  M M Hoskison; A N Moore; B Hu; S Orsi; N Kobori; P K Dash
Journal:  Neuroscience       Date:  2009-01-03       Impact factor: 3.590

View more
  40 in total

Review 1.  Phosphodiesterase inhibitors as therapeutics for traumatic brain injury.

Authors:  David J Titus; Anthony A Oliva; Nicole M Wilson; Coleen M Atkins
Journal:  Curr Pharm Des       Date:  2015       Impact factor: 3.116

2.  Altered regulation of protein kinase a activity in the medial prefrontal cortex of normal and brain-injured animals actively engaged in a working memory task.

Authors:  Nobuhide Kobori; Anthony N Moore; Pramod K Dash
Journal:  J Neurotrauma       Date:  2014-11-13       Impact factor: 5.269

3.  Inhibition of Eukaryotic Initiation Factor 2 Alpha Phosphatase Reduces Tissue Damage and Improves Learning and Memory after Experimental Traumatic Brain Injury.

Authors:  Pramod K Dash; Michael J Hylin; Kimberly N Hood; Sara A Orsi; Jing Zhao; John B Redell; Andrey S Tsvetkov; Anthony N Moore
Journal:  J Neurotrauma       Date:  2015-07-20       Impact factor: 5.269

4.  Repeated mild traumatic brain injury causes chronic neuroinflammation, changes in hippocampal synaptic plasticity, and associated cognitive deficits.

Authors:  Stephanie L Aungst; Shruti V Kabadi; Scott M Thompson; Bogdan A Stoica; Alan I Faden
Journal:  J Cereb Blood Flow Metab       Date:  2014-04-23       Impact factor: 6.200

5.  Rescue of impaired long-term facilitation at sensorimotor synapses of Aplysia following siRNA knockdown of CREB1.

Authors:  Lian Zhou; Yili Zhang; Rong-Yu Liu; Paul Smolen; Leonard J Cleary; John H Byrne
Journal:  J Neurosci       Date:  2015-01-28       Impact factor: 6.167

6.  Compartmentalized PDE4A5 Signaling Impairs Hippocampal Synaptic Plasticity and Long-Term Memory.

Authors:  Robbert Havekes; Alan J Park; Rosa E Tolentino; Vibeke M Bruinenberg; Jennifer C Tudor; Yool Lee; Rolf T Hansen; Leonardo A Guercio; Edward Linton; Susana R Neves-Zaph; Peter Meerlo; George S Baillie; Miles D Houslay; Ted Abel
Journal:  J Neurosci       Date:  2016-08-24       Impact factor: 6.167

7.  Induction of Neuronal PI3Kγ Contributes to Endoplasmic Reticulum Stress and Long-Term Functional Impairment in a Murine Model of Traumatic Brain Injury.

Authors:  Shan Liu; Rong Jin; Adam Y Xiao; Rui Chen; Jarvis Li; Wei Zhong; Xiaozhou Feng; Guohong Li
Journal:  Neurotherapeutics       Date:  2019-10       Impact factor: 7.620

8.  Rolipram Attenuates Early Brain Injury Following Experimental Subarachnoid Hemorrhage in Rats: Possibly via Regulating the SIRT1/NF-κB Pathway.

Authors:  Yucong Peng; Jianxiang Jin; Linfeng Fan; Hangzhe Xu; Pingyou He; Jianru Li; Ting Chen; Wu Ruan; Gao Chen
Journal:  Neurochem Res       Date:  2018-02-03       Impact factor: 3.996

Review 9.  Found in translation: Understanding the biology and behavior of experimental traumatic brain injury.

Authors:  Corina O Bondi; Bridgette D Semple; Linda J Noble-Haeusslein; Nicole D Osier; Shaun W Carlson; C Edward Dixon; Christopher C Giza; Anthony E Kline
Journal:  Neurosci Biobehav Rev       Date:  2014-12-10       Impact factor: 8.989

10.  RACK1 and β-arrestin2 attenuate dimerization of PDE4 cAMP phosphodiesterase PDE4D5.

Authors:  Graeme B Bolger
Journal:  Cell Signal       Date:  2015-08-06       Impact factor: 4.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.